Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening

医学 肺癌 癌症 内科学 肿瘤科 风险因素 头颈部癌 癌症流行病学 相对风险 入射(几何) 流行病学 癌症登记处 置信区间 乳腺癌 物理 光学
作者
Sara Nofal,Jiangong Niu,Paul J. Resong,Jeff Jin,Kelly W. Merriman,Xiuning Le,Hormuzd A. Katki,John V. Heymach,Mara B. Antonoff,Edwin J. Ostrin,Jia Wu,Jiexin Zhang,Iakovos Toumazis
出处
期刊:Cancer Medicine [Wiley]
卷期号:13 (5) 被引量:1
标识
DOI:10.1002/cam4.7069
摘要

Abstract Background Personal history of cancer is an independent risk factor for lung cancer but is omitted from existing lung cancer screening eligibility criteria. In this study, we assess the lung cancer risk among cancer survivors and discuss potential implications for screening. Methods This was a retrospective, secondary analysis of data from the Surveillance, Epidemiology and End Results (SEER) registry and the MD Anderson Cancer Center (MDACC). We estimated the standardized incidence ratios (SIRs) for lung cancer by site of first primary cancer using data from SEER. We assessed the lung cancer risk among head and neck cancer survivors from MDACC using cumulative incidence and compared the risk ratios (RR) by individuals' screening eligibility status. Results Other than first primary lung cancer (SIR: 5.10, 95% CI: 5.01–5.18), cancer survivors in SEER with personal history of head and neck cancer (SIR: 3.71, 95% CI: 3.63–3.80) had the highest risk of developing second primary lung cancer, followed by bladder (SIR: 1.86, 95% CI: 1.81–1.90) and esophageal cancers (SIR: 1.78, 95% CI: 1.61–1.96). Head and neck cancer survivors had higher risk to develop lung cancer compared to the National Lung Screening Trial's subjects, (781 vs. 572 per 100,000 person‐years, respectively). Head and neck cancer survivors ineligible for lung cancer screening seen at MDACC had significantly higher lung cancer risk than head and neck cancer survivors from SEER (RR: 1.9, p < 0.001). Conclusion Personal history of cancer, primarily head and neck cancer, is an independent risk factor for lung cancer and may be considered as an eligibility criterion in future lung cancer screening recommendations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
田様应助科研通管家采纳,获得10
5秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
徐国发应助科研通管家采纳,获得10
5秒前
rocky15应助科研通管家采纳,获得200
5秒前
Akim应助科研通管家采纳,获得10
5秒前
科研通AI2S应助科研通管家采纳,获得30
5秒前
完美世界应助科研通管家采纳,获得10
5秒前
竹筏过海应助科研通管家采纳,获得30
5秒前
JamesPei应助科研通管家采纳,获得10
5秒前
秋雪瑶应助科研通管家采纳,获得10
5秒前
CipherSage应助科研通管家采纳,获得10
5秒前
Lucas应助科研通管家采纳,获得10
5秒前
所所应助科研通管家采纳,获得10
5秒前
科研通AI2S应助科研通管家采纳,获得30
5秒前
5秒前
5秒前
酷波er应助炙热的羽毛采纳,获得10
6秒前
必发Nature完成签到,获得积分10
6秒前
所所应助一瞬明眸采纳,获得10
8秒前
薛沛然发布了新的文献求助10
9秒前
10秒前
10秒前
winwinwin887应助薛沛然采纳,获得10
13秒前
15秒前
科研通AI2S应助葛力采纳,获得10
15秒前
万能图书馆应助研友_5Y9775采纳,获得10
17秒前
南下发布了新的文献求助10
18秒前
18秒前
高高完成签到 ,获得积分10
18秒前
舒心访卉完成签到 ,获得积分10
19秒前
21秒前
木雨洛完成签到,获得积分10
22秒前
lzx完成签到,获得积分10
22秒前
李健应助KSLC采纳,获得10
23秒前
慕青应助重要的采白采纳,获得10
23秒前
慧慧完成签到,获得积分10
24秒前
24秒前
Jacqueline777发布了新的文献求助30
25秒前
高分求助中
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 1000
Corrosion and Oxygen Control 600
Python Programming for Linguistics and Digital Humanities: Applications for Text-Focused Fields 500
Heterocyclic Stilbene and Bibenzyl Derivatives in Liverworts: Distribution, Structures, Total Synthesis and Biological Activity 500
重庆市新能源汽车产业大数据招商指南(两链两图两池两库两平台两清单两报告) 400
Division and square root. Digit-recurrence algorithms and implementations 400
行動データの計算論モデリング 強化学習モデルを例として 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2547808
求助须知:如何正确求助?哪些是违规求助? 2176358
关于积分的说明 5603889
捐赠科研通 1897152
什么是DOI,文献DOI怎么找? 946662
版权声明 565412
科研通“疑难数据库(出版商)”最低求助积分说明 503895